Skip to main content
. 2020 Jun;95:198–203. doi: 10.1016/j.ijid.2020.03.081

Table 1.

Clinical information on the samples.

Patient Sample ID Unit Specimen date Sample type Age (years) Sex Diagnosis Antibiotic therapy Status at discharge
1 NM01 SMRU 25/7/07 CSF 7 M Meningitis Unknown Unknown
2 NM03 SMRU 25/11/09 BC 1 F Sepsis Ceftriaxone Well
3 NM04 SMRU 15/11/10 BC <1 M Meningitis Ceftriaxone Well
4 NM06 SMRU 19/6/11 BC 0.2 M Meningitis Unknown Unknown
5 NM07 SMRU 4/10/11 BC 0.5 M Meningitis Ceftriaxone Well
6 NM09 SMRU 7/1/12 BC 0.2 M Meningitis Ceftriaxone Well
7 NM11 SMRU 18/1/12 BC 3 M Meningitis Ceftriaxone Well
8 NM12 SMRU 28/12/12 BC 0.3 F Sepsis Ceftriaxone Well
9 NM13 SMRU 13/5/13 BC 0.6 M Sepsis Ceftriaxone Well
10 NM14 SMRU 15/2/14 BC 0.3 F Sepsis Ceftriaxone Well
11 NM15 SMRU 19/12/14 BC 0.3 M Sepsis Unknown Well
12 NM16 LOMWRU 10/11/17 CSF 60 F Meningitis Ceftriaxone Well
13 NM18 COMRU 13/10/13 BC 0.14 F Meningitis/Sepsis Ceftriaxone Well
14 NM19 COMRU 25/4/14 BC 1.84 F Sepsis Ceftriaxone Well
15 NM20 COMRU 31/3/15 BC 0.91 F Pneumonia/Sepsis Ceftriaxone Well
16 NM21 COMRU 24/7/16 BC 0.07 M Meningitis/Sepsis Unknown Well
17 NM23 COMRU 22/8/17 BC 0.33 F Meningitis Ceftriaxone Well
18 NM25 LOMWRU 21/3/18 BC 0.25 M Meningitis Ceftriaxone Well

SMRU, Shoklo Malaria Research Unit, Mae Sot, Thailand; LOMWRU, Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit, Vientiane, Laos; COMRU, Cambodia Oxford Medical Research Unit, Siem Reap, Cambodia.

CSF, cerebrospinal fluid; BC, blood culture.